Atea Pharmaceuticals Inc. (AVIR) – Downgrades
-
JPMorgan Downgrades Atea Pharmaceuticals (AVIR) to Underweight, 'Limited COVID Market With Cases and Hospitalizations Shrinking'
-
Morgan Stanley Downgrades Atea Pharmaceuticals (AVIR) to Underweight
-
-
-
-
-
Back to AVIR Stock Lookup